StonvexLoading…
StonvexStonvexStonvexCore line items from RNGR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $159.10M | $546.90M | $404.70M | $275.80M |
Operating Income | $5.10M | $15.40M | $12.20M | $9.60M |
Net Income | $3.00M | $12.30M | $9.10M | $7.90M |
EPS (Diluted) | $0.12 | $0.54 | $0.40 | $0.35 |
Total Assets | $459.20M | $419.30M | $372.80M | $381.70M |
Total Liabilities | $158.80M | $119.20M | $102.80M | $104.80M |
Cash & Equivalents | $6.90M | $10.30M | $45.20M | $48.90M |
Free Cash Flow OCF − CapEx | $-21.70M | $42.90M | $25.80M | $17.80M |
Shares Outstanding | 24.04M | 22.68M | 22.52M | 22.71M |